Modeling the population dynamics of HIV/AIDS Brandy L. Rapatski James A. Yorke Frederick Suppe.

Slides:



Advertisements
Similar presentations
Phases of HIV/AIDS 1. Infection 2. Window period 3. Seroconversion 4. Asymptomatic period 5. HIV/AIDS - related illness 6. AIDS.
Advertisements

1 Severe morbidity among HIV- infected patients : a comparison between a Brazilian and a French clinic based observational cohort FIOCRUZ: Prof B Grinsztejn.
Disease emergence in immunocompromised populations Jamie Lloyd-Smith Penn State University.
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
HIV True or False Module HIV/AIDS Activity 2: HIV:True or False.
HIV and STD in Maine Data from the Bureau of Health HIV/STD Program Contact: Mark Griswold (207)
Spectrum 2007 Overview and New Changes UNAIDS Reference Group on Estimates, Model and Projections 2007.
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
Modelling HIV/AIDS in Southern Africa Centre for Actuarial Research (CARe) A Research Unit of the University of Cape Town.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
Primary HIV Infection: the CDC study Pragna Patel, MD MPH Medical Epidemiologist Behavioral and Clinical Surveillance Branch DHAP, CDC February 28, 2005.
Modelling – progress update Stephen Catterall, BioSS 28 th November 2007.
HIV Epidemic at 30 Years Where we ’ ve been and where we ’ re going Ann M. Khalsa, MD, MSEd, AAHIVS McDowell (HIV/AIDS) Healthcare Center, MIHS Arizona.
HIV dynamics in sequence space Shiwu Zhang Based on [Kamp2002from, Kamp2002co-evolution]
Epidemiology and Public Health Introduction, Part II.
The AIDS Epidemic Presented by Jay Wopperer. HIV/AIDS-- Public Enemy #1?
1 The epidemic in a closed population Department of Mathematical Sciences The University of Liverpool U.K. Roger G. Bowers.
Presentation Package for Concepts of Fitness and Wellness 6e Section VII: Concept 23 Preventing Sexually Transmitted Diseases.
INTERACTION BETWEEN VIRUSES AND HOST CELLS Dr AYMAN JOHARGY 3 rd Year Medicine Clinical Microbiology 2 nd Semester Lecture 4 3 rd Year Medicine Clinical.
Natural History and Clinical Staging of HIV Training for Medical Officers Day 2 Session 7.
Human Immunodeficiency Virus Part II VIRUSES. TYPES OF HIV There are two types of HIV HIV-1 and HIV-2 Can be distinguished genetically and antigenically.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis,
HIV/AIDS. HIV/AIDS Vocabulary HIV Human (only in humans) Immune (fights infections) deficiency (lack something) Virus (infection that cannot be cured)
INDIA and HIV/AIDS Student Example 2009 Comprehensive Health Education.
The Silent Epidemic Any pathogen that spreads from one person to another during sexual contact is called a sexually transmitted infection, or STI. More.
Texas Medical Monitoring Project (MMP) Meeting Omni Austin Hotel at Southpark Thursday, May 31, 2007 a multi-stage probability sample of HIV infected adults.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Clinical Care of HIV, AIDS and Opportunistic Infections
Brandy L. Rapatski Juan Tolosa Richard Stockton College of NJ A Model for the Study of HIV/AIDS.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
V5 Epidemics on networks
1 OPA/OFP HIV Prevention Project Annual Technical Support Conference Six Years of HIV Supplemental Grants – A National Perspective Susan B. Moskosky Director,
HIV Among People Aged 50 and Older Trainer Slides May 2015.
Epidemiology With Respect to the Dynamics of Infectious Diseases Huaizhi Chen.
Welcome to “STD 101 in a Box” Developed by Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
WIHS was established in 1993 to investigate the impact and progression of HIV in women.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
Mathematical Modeling of Bird Flu Propagation Urmi Ghosh-Dastidar New York City College of Technology City University of New York December 1, 2007.
PhD We knew nothing about the set-point viral loads. What was unknown about HIV-1 infection before this paper was published in 2007? 1.Virus density.
BISEXUAL CONCURRENCY,BISEXUAL PARTNESHIPS,AND HIV AMONG SOUTHERN AFRICA MEN WHO HAVE SEX WITH MEN (MSM) Presenter: Gift Trapence Organisation: Centre for.
© Guidant 2005 Surrogate Endpoints and Non-randomized Trials Roseann White Humble Biostatistician.
 Life Expectancy is 180 th in the World.  Literacy Rate is 4 th in Africa.
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
Other Sexually Transmitted Diseases Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
Human rights violations, discrimination and homophobia in Kenya; The experience of a HIV positive Kenyan sex worker and the work of a community-based support.
TIMELINE.  1 st wave – mid 1970’s –The Invisible Wave  2 nd wave – early 1980’s – HIV/AIDS discovered * 1981 – 6 cases of pneumocystic pneumonia diagnosed.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
HIV Surveillance in Women National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Projected Population and HIV/AIDS Update 18 May 2011 National Health Insurance Policy Brief 18.
THURSD AY 4/28/16 CNN STUDENT NEWS -Discussion POWERPOINT LESSON: -The Urban 80s INDEPENDENT WORK -Chapter 15 Outline -Chapter 15 Activities/Worksheets.
Trends in the Prevalence of Hepatitis C and Hepatitis B and HIV in Seattle Injection Drug Users, 18 – 30 years old, Richard Burt, Holly Hagan,
Prospective Observational European Study of the natural history and Treatment of Syphilis in HIV positive individuals – The POETS Study Rowley D 1, Fätkenheuer.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Using implementation science to improve child household contact screening for tuberculosis in Eldoret, Kenya: Overview and lessons learned Daria Szkwarko,
Mathematical modelling of male circumcision in sub-Saharan Africa predicts significant reduction in HIV prevalence Greg Londish 1, John Murray 1,2 1 School.
UNIT II: HIV/AIDS RISKS FACTORS & DIAGNOSIS Quinnie Paz V. Teng R.N.
Sexually Transmitted Infections Bacterial Viral Parasitic.
Update on epidemiology of HIV in New Zealand Dr Sue McAllister AIDS Epidemiology Group (AEG) University of Otago Dunedin HIV Women’s Seminar Auckland,
Accounting for uncertainty in the timing of seroconversion in combined models for pre- and post-treatment CD4 counts in HIV-patients Oliver Stirrup, Andrew.
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Illustrating the HIV Care Continuum in U.S. Cities
Objectives: Ch. 11 Understand the difference between infection and disease Understand the nature of symbiosis humans enjoy with microorganisms and the.
The HIV Epidemic among People who Inject Drugs
Analytic framework illustrating exposure to preventive measures that reduce the risk of transmission between HIV-serodiscordant sex partners. Analytic.
MSM Attending STD Clinics HIV Testing More Frequently: Implications for HIV Prevention and Surveillance D Helms1, H Weinstock1, K Mahle1, A Shahkolahi1,2,
Division of STD Prevention Centers for Disease Control and Prevention
Centers for Disease Control and Prevention guidelines for evaluating the risk of HIV transmission after occupational exposure (PEP, post-exposure prophylaxis).
Presentation transcript:

Modeling the population dynamics of HIV/AIDS Brandy L. Rapatski James A. Yorke Frederick Suppe

Primary Goal To determine how infectiousness of HIV varies as an untreated infected gay man progresses through 3 stages of the disease. Any attempt to measure these infectivities must be a highly mathematical analysis of available data.

Modeling SF Gay Population We model the San Francisco population as described by the San Francisco City Clinic Cohort Study (SFCCC).

San Francisco Transmission Dynamics Analysis of Six Activity Levels (from survey data) Infectiousness depends on stage (3 stages) Bathhouse Assumption Men vary in how often they visit the bathhouses but once inside choose partners at random. Model must account for SF data

Infectivity Per Contact Conclusions 2/3 Year 7 Years3 Years First Stage Infectivity Second Stage Infectivity Third Stage Infectivity Death Total infections = *2/3= *7= *3=0.669

First StageSecond StageThird Stage Previous variable-infectivity SFCCC models (Jacquez-Koopman et al. 1994) ~ ~0.005 Our SFCCC variable- infectivity model ~0.020 (factor of 1/6) ~0.300 (factor of 60) Infectivity Comparison

Viral Loads Variable viral loads over the course of a typical untreated individual’s HIV infection. [ nd Stage ] [1 st Stage][ rd Stage----] Our infectivities correspond to viral loads

The infectivities reflect the pattern of semen infectivity. Though infectivity depends on mode of transmission, third stage remains most infectious.

Person-to-Person Transition Rate Africa: 1 person to 1,000,000 in approximately 40 years ( ) ModelMean Transmission Time Infections caused per individual Previous variable- infectivity SFCCC models Our SFCCC variable- infectivity model 1.3 years 6.9 years ~31 generations in 40 years ~6 generations in 40 years

Contact Information